CIDRAP
“We are living in unprecedented times when it comes to modern vaccine review and recommendation,” said Michael Osterholm, PhD, MPH, CIDRAP director and coauthor of an accompanying commentary. “The VIP program will never replace ACIP [Advisory Committee on Immunization Practices]. In the interim, it’s the stopgap measure that allows us to continue recommending these vaccines based on a comprehensive review of both effectiveness and safety.”